BNS, update

Then, Sept. 2014, and now charts, as usual;

bns may 28 2014 bbns 23 sept 2016

Precisely two years ago when the stock was trading at about $70, our expectation was that it would trade to the other side of the channel in which it had been for most of our (working) lives. That blog is still available for you to see. The rational for this expectation, at least in EW terms, was that we had, or were about to complete a very large and irregular B wave. In reality the stock traded from a slightly higher level of about $75 down to $50, a drop of 30%! It failed to reach the other side by only a few dollars, but it did overlap with the all-time orthodox high of $55 set in 2007, potentially a very bad sign.

     The B wave is on the border of what might be considered acceptable for the size of a B wave, i.e. 30% higher than the previous top. This leaves open the possibility that it wasn’t a B wave at all. Instead it could have been a 5th wave. Either way the next big move should take the stock down to about $25, alternatively the low of wave A, or the low of the 4th wave of previous degree. Depending on that the wave C down in the former case should start its third wave down any moment having finished wave 2, or, in the latter case it has just completed a wave b to be followed by a 5-wave (smaller) wave c.

For comparison purposes we show HCG and CWB below. These are small Canadian banks and consequently perhaps a bit more volatile. We expected HCG to go a little lower before closing the gap. It did not but the it did close the gap. But now we are close to the lows for both of these banks supporting the notion that lower levels for all banks may be in the cards,

hcg sept 23 2016cwb sept 23 2016

CXR, Concordia Healthcare

cxr sept 16 2016

We like this stock at these levels. It has lost about 95% of it’s peak value and appears to have done so in what is best described as a double zig-zag.  Supposedly today’s large drop was due to the British Government having decided that generic drugmakers may no longer price at will. We have no idea why CXR would be affected other than that we assume that they sell some of their stuff in the UK.

The RSI has been oversold for about two months during which the stock dropped by 2/3. It is a full moon tonight and that is when you want to buy a stock like this. In fact at 3.05 p.m. tonight we will have a Harvest Moon and a lunar eclipse, and that is the perfect time to do something silly like buying this stock. We do recommend selling it again after a 50% gain after just a few days.

TCK.B Teck Cominco update.

tck.b sept 14 2016

Teck has been one of our best calls despite the fact that we expected a bigger pull-back in wave 2. Otherwise the target has always been around $26 for a variety of reasons that can be found in previous blogs. Given the very clear equal legs up we would not wait for this level to materialize and would simple sell now for a gain of at least 400/500% for anyone that continued to hold this stock from the low of about $4 as anticipated in earlier blogs.

     At this point we are not at all sure what the count is from the bottom or if it is actually a new bull market, so, when in doubt get out.